ArticleClinical and translational medicine2022

TRIM28 attenuates Bortezomib sensitivity of hepatocellular carcinoma cells through enhanced proteasome expression.

Jianchao Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.